Indeed, immunotherapy plays a major role in melanoma [20] with extraordinary responses in patients treated with immune checkpoint inhibitors and we have previously demonstrated the spontaneous immunogenicity of cutaneous melanoma by the frequent expression on CT7 and CT10 and spontaneous immune responses to CT7 in these patients. This evidence concerns the gene MAGEC2 and cutaneous melanoma.